Chemoimmunotherapy of experimental hepatic metastases.

Abstract	Previous studies from our laboratory have demonstrated that particulate glucan is efficacious in the therapy of a syngeneic murine reticulum cell sarcoma (M5706), which specifically metastasizes from its primary site to the liver. The present study was undertaken to examine the therapeutic efficacy of a newly developed soluble glucan, in combination with cyclophosphamide in the treatment of hepatic metastatic disease. Male C57Bl/6J mice were injected subcutaneously on Day 0 with 1 x 10(4) sarcoma cells. Glucan (200 mg per kg i.v.), cyclophosphamide (45 mg per kg i.p.) or glucan and cyclophosphamide were administered beginning on Day 20, when hepatic metastases were evident, and continued at 3-day intervals up to Day 50. Combined therapy with glucan and cyclophosphamide resulted in reduction of hepatic metastatic lesions on Day 36, compared to control. Survival data revealed that the combination of glucan and cyclophosphamide significantly (p less than 0.001) extended median survival time and the time to 100% mortality in an additive fashion, when compared to either therapy alone. Glucan-cyclophosphamide therapy was also effective in decreasing primary tumor weight to a level that was significantly (p less than 0.05) less than when therapy was initiated. In vitro studies revealed that Kupffer cell tumoricidal activity against sarcoma was increased (p less than 0.05) following glucan and cyclophosphamide. Glucan and cyclophosphamide also enhanced bone marrow proliferation and splenocyte response to mitogens in vitro. Additionally, glucan was observed to exert a direct cytostatic effect on sarcoma in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors	D L Williams, E R Sherwood, R B McNamee, E L Jones, I W Browder, N R Di Luzio
Journal	Hepatology (Baltimore, Md.) (Hepatology) 1987 Nov-Dec Vol. 7 Issue 6 Pg. 1296-304 ISSN: 0270-9139 [Print] United States
PMID	3315933 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Glucans Cyclophosphamide
Topics	Animals Cyclophosphamide (administration & dosage, therapeutic use) Drug Therapy, Combination Glucans (administration & dosage, therapeutic use) Immunotherapy Liver Neoplasms (secondary, therapy) Lymphoma, Large B-Cell, Diffuse (secondary, therapy) Male Mice Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!